422 related articles for article (PubMed ID: 9887158)
1. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
Hartmann LC; Schaid DJ; Woods JE; Crotty TP; Myers JL; Arnold PG; Petty PM; Sellers TA; Johnson JL; McDonnell SK; Frost MH; Jenkins RB
N Engl J Med; 1999 Jan; 340(2):77-84. PubMed ID: 9887158
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; van Geel B; van Putten WL; Henzen-Logmans SC; Seynaeve C; Menke-Pluymers MB; Bartels CC; Verhoog LC; van den Ouweland AM; Niermeijer MF; Brekelmans CT; Klijn JG
N Engl J Med; 2001 Jul; 345(3):159-64. PubMed ID: 11463009
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
7. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic bilateral mastectomy: patterns of practice.
Metcalfe KA; Goel V; Lickley L; Semple J; Narod SA
Cancer; 2002 Jul; 95(2):236-42. PubMed ID: 12124821
[TBL] [Abstract][Full Text] [Related]
9. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
[TBL] [Abstract][Full Text] [Related]
11. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
[TBL] [Abstract][Full Text] [Related]
12. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
McLaughlin CC; Lillquist PP; Edge SB
Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
[TBL] [Abstract][Full Text] [Related]
14. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
[TBL] [Abstract][Full Text] [Related]
15. Is family history related to preventive health behaviors and medical management in breast cancer patients?
Madlensky L; Flatt SW; Bardwell WA; Rock CL; Pierce JP;
Breast Cancer Res Treat; 2005 Mar; 90(1):47-54. PubMed ID: 15770526
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
17. Predictors of and satisfaction with bilateral prophylactic mastectomy.
Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
[TBL] [Abstract][Full Text] [Related]
18. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
19. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
20. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
Isern AE; Loman N; Malina J; Olsson H; Ringberg A
Eur J Surg Oncol; 2008 Oct; 34(10):1148-54. PubMed ID: 18434071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]